Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ADMAthis companyADMA Biologics, Inc.	$12.79	29.42×	9.11×	8.52×	21.93×	-1001.8%	57.4%	37.5%	28.8%	30.8%	27.6%	0.6%	0.17×	-0.04×	26.93×	6.71×	0.0%	5	8.39	3	B+
ABUSArbutus Biopharma Corp	$3.72	-28.29×	12.04×	65.44×	-27.47×	-169.0%	97.4%	-192.1%	-237.9%	-43.7%	-30.3%	-4.3%	0.05×	0.42×	-278.88×	15.73×	0.0%	5	25.89	4	A-
IVVDInvivyd, Inc.	$0.60	-8.23×	1.76×	7.96×	-3.99×	1703.4%	93.0%	-104.0%	-98.2%	-21.7%	-22.8%	-13.7%	0.01×	4.45×	0×	7.24×	0.0%	1	-4.47	3	B
Peer median	—	-18.26×	6.9×	36.7×	-15.73×	767.2%	95.2%	-148.0%	-168.1%	-32.7%	-26.6%	-9.0%	0.03×	2.43×	-139.44×	11.49×	0.0%	3	10.71	4	—